Still reeling from an accounting scandal, the Japanese company feels pressured to sell off one of the few bright spots in the company: its medical division. The sale could be worth billions of dollars.
Still reeling from an accounting scandal, the Japanese company feels pressured to sell off one of the few bright spots in the company: its medical division. The sale could be worth billions of dollars.